Evidence map›Paper›PMID 39794140›Full record

ArticleThe Journal of comparative neurology2025

Ultrastructural Localization of Glutamate Delta Receptor 1 in the Rodent and Primate Lateral Habenula.

Diane Choi, Jean-Francois Paré, Shashank Dravid, Yoland Smith

Abstract read
In one paragraph

Article in The Journal of comparative neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Glutamate Delta 1 Receptor in Synapses, Circuits, and Disease.The European journal of neuroscience · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Diane ChoiGraduate Program in Molecular and Systems Pharmacology, Emory University, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-2326-5197
Jean-Francois ParéDepartment of Neurology, Emory University, Atlanta, Georgia, USA.
Shashank DravidDepartment of Psychiatry and Behavioral Sciences, Texas A&M University, College Station, Texas, USA.
Yoland SmithGraduate Program in Molecular and Systems Pharmacology, Emory University, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-8700-878X

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Graduate Training in the Pharmacological StudiesT32GM008602 · NIGMS · EMORY UNIVERSITY · PI HALL, RANDY A. · 1996 to 2021
$5.1M
Trans-synaptic signaling complex in amygdala pain mechanismsR01NS118731 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DRAVID, SHASHANK MANOHAR, NEUGEBAUER, VOLKER · 2020 to 2024
$2.7M
Striatal Trans-Synaptic Signaling Mechanism in ParkinsonismR01NS133338 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI Hong-Yuan Chu, Shashank Manohar Dravid · 2024 to 2026
$2.0M
Function of glutamate delta-1 receptorR01MH116003 · NIMH · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DRAVID, SHASHANK MANOHAR · 2018 to 2022
$1.9M
Structure-Function and Signaling of Glutamate Delta 1 in Pain MechanismR21NS132590 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DRAVID, SHASHANK MANOHAR · 2023 to 2023
$404k
Molecular mechanism of D-cycloserine actionR21MH085327 · NIMH · CREIGHTON UNIVERSITY · PI DRAVID, SHASHANK MANOHAR · 2010 to 2011
$396k
NIGMS NIH HHS T32 GM008602NIH HHS P51 OD011132NIH HHS P51OD011132NIH HHS R01 NS118731NIH HHS T32 GM 8602-24NIMH NIH HHS R01 MH116003NIMH NIH HHS R21 MH085327NINDS NIH HHS R01 NS118731NINDS NIH HHS R01 NS133338NINDS NIH HHS R21 NS132590
6 · The paper itself

Abstract

Glutamate delta receptor 1 (GluD1) is a unique synaptogenic molecule expressed at excitatory and inhibitory synapses. The lateral habenula (LHb), a subcortical structure that regulates negative reward prediction error and major monoaminergic systems, is enriched in GluD1. LHb dysfunction has been implicated in psychiatric disorders such as depression and schizophrenia, both of which are associated with GRID1, the gene that encodes GluD1. Thus, disruption in GluD1 synaptic signaling may contribute to LHb dysfunction and the pathophysiology of LHb-associated disorders. Despite its strong cellular expression, little is known about the subsynaptic and subcellular localization of GluD1 in LHb neurons. Given that GluD1 is involved in the development and/or regulation of glutamatergic and GABAergic synapses in various brain regions, a detailed map of GluD1 synaptic localization is essential to elucidate its role in the LHb. To address this issue, we used immunoelectron microscopy methods in rodents and monkeys. In both species, GluD1 immunoreactivity was primarily expressed in dendritic profiles, with lower expression in somata, spines, and glial elements. Pre- and post-embedding immunogold experiments revealed strong GluD1 expression in the core of symmetric GABAergic synapses. Albeit less frequent, GluD1 was also found at the edges (i.e., perisynaptic) of asymmetric, putative glutamatergic synapses. Through the combination of anterograde tracing with immunogold labeling in rats, we showed that axon terminals from the entopeduncular nucleus and the lateral hypothalamus express postsynaptic GluD1 immunolabeling in the LHb. Our findings suggest that GluD1 may play a critical role in modulating GABAergic transmission in the rodent and primate LHb.

Indexed as

HabenulaNeuronsReceptors, GlutamateAnimalsFemaleMacaca mulattaMaleMiceMicroscopy, ImmunoelectronRatsRats, Sprague-DawleySynapsesglutamate receptor delta 1Receptors, Glutamateelectron microscopyentopeduncular nucleusGABAGABAergic synapseglutamatergic synapselateral hypothalamusprimate

Identifiers

PMID39794140
PMCPMC11723828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.